5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.74▼ | 8.40▼ | 8.40▼ | 8.08▲ | 7.97▲ |
MA10 | 8.27▲ | 8.11▲ | 8.11▲ | 8.21▲ | 7.81▲ |
MA20 | 7.77▲ | 7.53▲ | 7.53▲ | 8.03▲ | 7.92▲ |
MA50 | 7.91▲ | 8.02▲ | 8.10▲ | 7.58▲ | 8.37▲ |
MA100 | 8.03▲ | 8.04▲ | 8.05▲ | 7.95▲ | 10.26▼ |
MA200 | 8.20▲ | 8.47▼ | 8.85▼ | 8.15▲ | 14.17▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.125▲ | 0.163▲ | 0.164▲ | -0.012▼ | 0.136▲ |
RSI | 54.794▲ | 55.023▲ | 54.560▲ | 55.838▲ | 51.933▲ |
STOCH | 69.728 | 74.253 | 74.253 | 17.277▼ | 45.660 |
WILL %R | -36.066 | -36.066 | -36.066 | -75.152▼ | -49.600 |
CCI | 45.252 | 69.745 | 69.745 | 39.889 | 69.883 |
Wednesday, May 15, 2024 01:43 PM
ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- (“Gray,” the “Company,” “we,” or “our”) (NYSE: GTN) announced today the commencement of a refinancing process for its existing $1.15 billion term loan due ...
|
Wednesday, May 15, 2024 05:19 AM
Q1 2024 Earnings Call Transcript May 14, 2024 Operator: Good day and welcome to Arcutis Biotherapeutics’ 2024 First Quarter Financial Results Conference Call. At this time, all participants are in a ...
|
Wednesday, May 15, 2024 05:18 AM
Q1 2024 Earnings Call Transcript May 14, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the scPharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/05/24 | 8.42 | 8.42 | 8.42 | 8.42 | 200 |
15/05/24 | 8.19 | 8.19 | 8.19 | 8.19 | 38 |
14/05/24 | 8.19 | 8.19 | 8.19 | 8.19 | 100 |
10/05/24 | 8.00 | 8.00 | 8.00 | 8.00 | 200 |
09/05/24 | 7.60 | 7.60 | 7.60 | 7.60 | 14 |
08/05/24 | 8.25 | 8.25 | 7.60 | 7.60 | 1,300 |
07/05/24 | 8.25 | 8.25 | 8.25 | 8.25 | 500 |
06/05/24 | 9.07 | 9.07 | 8.41 | 8.42 | 953 |
03/05/24 | 8.28 | 8.7959 | 8.28 | 8.7959 | 785 |
02/05/24 | 8.10 | 10.90 | 8.00 | 8.60 | 23,726 |
|
|
||||
|
|
||||
|
|